Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 735

1.

Randomized, Open-Label Phase 2 Study Comparing Frontline Dovitinib vs Sorafenib in Patients With Advanced Hepatocellular Carcinoma.

Cheng AL, Thongprasert S, Lim HY, Sukeepaisarnjaroen W, Yang TS, Wu CC, Chao Y, Chan SL, Kudo M, Ikeda M, Kang YK, Pan H, Numata K, Han G, Balsara B, Zhang Y, Rodriguez AM, Zhang Y, Wang Y, Poon RT.

Hepatology. 2016 Apr 15. doi: 10.1002/hep.28600. [Epub ahead of print]

PMID:
27082062
2.

Differences in health-related quality of life between European and Asian patients with hepatocellular carcinoma.

Chie WC, Blazeby JM, Hsiao CF, Chiu HC, Poon RT, Mikoshiba N, Al-Kadhim G, Heaton N, Calara J, Collins P, Caddick K, Costantini A, Vilgrain V; Chieh CHIANG, on behalf of the EORTC QUALITY OF LIFE GROUP.

Asia Pac J Clin Oncol. 2016 Apr 1. doi: 10.1111/ajco.12464. [Epub ahead of print]

PMID:
27038366
3.

Internet Vigilantism: Attitudes and Experiences of University Students Toward Cyber Crowdsourcing in Hong Kong.

Chang LY, Poon R.

Int J Offender Ther Comp Criminol. 2016 Mar 18. pii: 0306624X16639037. [Epub ahead of print]

PMID:
26992831
4.

Zika virus infection-the next wave after dengue?

Wong SS, Poon RW, Wong SC.

J Formos Med Assoc. 2016 Apr;115(4):226-42. doi: 10.1016/j.jfma.2016.02.002. Epub 2016 Mar 7. Review.

5.
6.

Hepatitis B virus full-length genomic mutations and quasispecies in hepatocellular carcinoma.

Zhang AY, Lai CL, Poon RT, Huang FY, Seto WK, Fung J, Wong DK, Yuen MF.

J Gastroenterol Hepatol. 2016 Feb 15. doi: 10.1111/jgh.13316. [Epub ahead of print]

PMID:
26905957
7.

Risk Factors and Post-Resection Independent Predictive Score for the Recurrence of Hepatitis B-Related Hepatocellular Carcinoma.

Hung IF, Wong DK, Poon RT, Fong DY, Chui AH, Seto WK, Fung JY, Chan AC, Yuen JC, Tiu R, Choi O, Lai CL, Yuen MF.

PLoS One. 2016 Feb 22;11(2):e0148493. doi: 10.1371/journal.pone.0148493. eCollection 2016.

8.

First Report of Laribacter hongkongensis Peritonitis in Continuous Ambulatory Peritoneal Dialysis.

Woo PC, Poon RW, Foo CH, To KK, Lau SK.

Perit Dial Int. 2016 1-2;36(1):105-107.

PMID:
26838992
9.

TRIP13 Regulates Both the Activation and Inactivation of the Spindle-Assembly Checkpoint.

Ma HT, Poon RY.

Cell Rep. 2016 Feb 9;14(5):1086-99. doi: 10.1016/j.celrep.2016.01.001. Epub 2016 Jan 28.

10.

Acute pancreatitis induced by transarterial chemoembolization: a single-center experience of over 1500 cases.

She WH, Chan AC, Cheung TT, Chok KSh, Chan SC, Poon RT, Lo CM.

Hepatobiliary Pancreat Dis Int. 2016 Feb;15(1):93-8.

11.

Efficacy of radiofrequency ablation compared with transarterial chemoembolization for the treatment of recurrent hepatocellular carcinoma: a comparative survival analysis.

Koh PS, Chan AC, Cheung TT, Chok KS, Dai WC, Poon RT, Lo CM.

HPB (Oxford). 2016 Jan;18(1):72-8. doi: 10.1016/j.hpb.2015.07.005.

12.

Yttrium-90 radioembolization for advanced inoperable hepatocellular carcinoma.

Lee VH, Leung DK, Luk MY, Tong CC, Law MW, Ng SC, Wong KK, Poon RT, Kwong DL, Leung TW.

Onco Targets Ther. 2015 Nov 20;8:3457-64. doi: 10.2147/OTT.S92473. eCollection 2015.

13.

SGO1C is a non-functional isoform of Shugoshin and can disrupt sister chromatid cohesion by interacting with PP2A-B56.

Wong WK, Kelly T, Li J, Ma HT, Poon RY.

Cell Cycle. 2015;14(24):3965-77. doi: 10.1080/15384101.2015.1104439.

PMID:
26506018
14.

Efficacy of radiofrequency ablation compared with transarterial chemoembolization for the treatment of recurrent hepatocellular carcinoma: a comparative survival analysis.

Koh PS, Chan AC, Cheung TT, Chok KS, Dai WC, Poon RT, Lo CM.

HPB (Oxford). 2015 Oct 16. doi: 10.1111/hpb.12495. [Epub ahead of print]

PMID:
26473770
15.

The Utility of Positron Emission Tomography in Epilepsy.

Burneo JG, Poon R, Kellett S, Snead OC.

Can J Neurol Sci. 2015 Nov;42(6):360-71. doi: 10.1017/cjn.2015.279. Epub 2015 Oct 6.

PMID:
26437611
16.

A sensitive and specific antigen detection assay for Middle East respiratory syndrome coronavirus.

Chen Y, Chan KH, Kang Y, Chen H, Luk HK, Poon RW, Chan JF, Yuen KY, Xia N, Lau SK, Woo PC.

Emerg Microbes Infect. 2015 Apr;4(4):e26. doi: 10.1038/emi.2015.26. Epub 2015 Apr 22.

17.

A preclinical study on the combination therapy of everolimus and transarterial chemoembolization in hepatocellular carcinoma.

Chow AK, Yau TC, Ng L, Chu AC, Law WL, Poon RT, Pang RW.

Am J Cancer Res. 2015 Jul 15;5(8):2376-86. eCollection 2015.

18.

Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial.

Bruix J, Takayama T, Mazzaferro V, Chau GY, Yang J, Kudo M, Cai J, Poon RT, Han KH, Tak WY, Lee HC, Song T, Roayaie S, Bolondi L, Lee KS, Makuuchi M, Souza F, Berre MA, Meinhardt G, Llovet JM; STORM investigators.

Lancet Oncol. 2015 Oct;16(13):1344-54. doi: 10.1016/S1470-2045(15)00198-9. Epub 2015 Sep 8.

PMID:
26361969
19.

Timeless Interacts with PARP-1 to Promote Homologous Recombination Repair.

Xie S, Mortusewicz O, Ma HT, Herr P, Poon RR, Helleday T, Qian C.

Mol Cell. 2015 Oct 1;60(1):163-76. doi: 10.1016/j.molcel.2015.07.031. Epub 2015 Sep 3.

PMID:
26344098
20.

Pure Laparoscopic Versus Open Left Lateral Sectionectomy for Hepatocellular Carcinoma: A Single-Center Experience.

Cheung TT, Poon RT, Dai WC, Chok KS, Chan SC, Lo CM.

World J Surg. 2016 Jan;40(1):198-205. doi: 10.1007/s00268-015-3237-8.

PMID:
26316115
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk